Raymond James Financial Inc Dynavax Technologies Corp Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 14,496 shares of DVAX stock, worth $150,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,496
Previous 15,996
9.38%
Holding current value
$150,758
Previous $207,000
30.92%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DVAX
# of Institutions
293Shares Held
120MCall Options Held
294KPut Options Held
86.1K-
Black Rock Inc. New York, NY21.9MShares$228 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$185 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$87.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$66.5 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$44.8 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.32B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...